Market Overview

What Caused The Opening Gap In Deciphera Pharmaceuticals?


For real-time updates on DCPH, beat the news and login or try Benzinga Pro.

Deciphera Pharmaceuticals (NASDAQ: DCPH) today had a large opening gap of 53.50%.

Photo taken from the Opening Gap Signals tool inside Benzinga Pro.

Why Is DCPH Moving?

Deciphera Pharmaceuticals shares are trading higher after the company reported a positive update that its Phase 1 Data for Ripretinib in gastrointestinal stromal tumors achieved primary endpoint.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

For live updates on DCPH, log in or try Benzinga Pro today.

Posted-In: Biotech News Intraday Update General


Related Articles (DCPH)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Q&A: CohnReznick Asks IIP CEO how Cannabis Operators Can Make The REIT's Radar

Pattern Energy Confirms Approaches By Third Parties